Position in ANIP
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$215,228
-$92 QoQ
Shares Held
2,600
-7.1% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#224
of 305 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Carnegie Investment Counsel holds $5,774,820 across 2 Drug Manufacturers - Specialty & Generic names. ANIP ranks #2 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
77,367 | $5,559,592 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
This page
|
2,600 | $215,228 |
All Filings in ANIP
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $215,228 | 2,600 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $215,320 | 2,800 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $221,032 | 2,800 | Shares | Sole | 2026-01-23 | |
| No filing history on record for this holder in this stock. | ||||||